Welcome to peppersite
Everything we know about peptides, read against the paper.
Browse the audits, look a compound up, run the bench math, or ask the room. Start anywhere. Peppersite checks the claim so you do not have to take it on faith.
Explore peppersite
The latest
All audits →Claim audit · SemaxAnimal
Semax Isn't Under-Researched. It's Under-Translated.
Decades of work exists on this peptide. Almost nothing an English reader can actually open says a word about human cognition, and I sell the stuff.
Claim audit · SemaxAnimal
Semax Is Approved in Russia. That's a Fact About a Regulator, Not a Result.
I went looking for the human trial I could hand you and came back with mice, a negative result, and one honest reason the Western data is thin.
Claim audit · SemaxAnimal
Everyone Opens With "Semax Is Approved in Russia." Approval and Replication Are Two Different Columns.
A three-column test for reading any compound whose evidence sits behind a language border, and what the English-language literature on Semax actually contains.
Claim audit · SemaxAnimal
"It's an Approved Drug in Russia." That's the Weakest Argument for Semax, Not the Strongest.
Semax has a real evidence base, which is exactly what makes it easy to overstate: almost none of it was collected in healthy people at a desk, and almost nobody outside its home research tradition has checked it.
Claim audit · SemaxAnimal
Semax Has Been Used Clinically for Decades. That's a Claim About Russia, Not About Cognition.
The most convincing sentence in the Semax conversation is a fact about a healthcare system, and buyers keep mistaking it for evidence about a molecule.
Claim audit · retatrutide
Lilly Sued Six Sellers Over Retatrutide. The Real Defendant Is Three Words.
The suits are aimed at "research use only", which is the sentence this whole market is built on, including the footer of the shop you buy from.
Claim audit · retatrutide
Lilly Cannot Sue Anyone for Selling an Unapproved Drug. So What Is the Claim?
A reader asked how you sue over a drug nobody is allowed to sell yet. The answer runs through a 2014 Supreme Court case and one word in it: "or".
Claim audit · BPC-157Expert commentary
BPC-157 Wasn't Banned. It Was Left Off a List.
Four separate regulatory facts get crushed into the word 'legal,' and almost every confident answer online is answering a question you didn't ask.
Claim audit · SemaxAnimal
"Approved in Russia Since the 1990s." That's a Fact About Russia, Not About Semax.
I sell Semax, and when I followed the claims about it back to their sources, most of them stopped within two clicks. Here's how to tell which ones stop where.
Claim audit · GHK-CuAnimal
GHK-Cu and KPV Are Both Three Amino Acids Long. That's Where the Resemblance Ends.
They share a shelf heading, not a mechanism. Here is the four-point test I run before I let the word "versus" into a sentence about two compounds.
Claim audit · MOTS-cAnimal
MOTS-c and SS-31 Are Not Two Versions of the Same Idea. One Is a Signal, One Is a Scaffold.
They share an address inside the cell and almost nothing else, which is why reading one's evidence into the other will steer you wrong.
Clip
2:44Why this exists
Clip
1:26Epitalon's entire claim to fame is one enzyme
Claim audit · CJC-1295Expert commentary
Tesamorelin Is Approved. CJC-1295 Is Living Off Its Reputation.
The GH-axis peptides are not one evidence base, they're a steep ladder, and the rung most buyers think they're standing on isn't the one they're on.
18
audits published
192
claims graded
69
compounds tracked
For in-vitro research use only · not for human consumption of any kind. Commerce lives on Teton Labs and requires a signed research disclosure.
Claims, checked against the paper
Everything peptides, in one place you can trust.
Audits that grade the evidence, a reference knowledge base, a working bench calculator, member discussion, and video, with commerce kept at arm’s length in our supplier’s catalog.
18
Audits published
192
Claims graded
69
Compounds referenced
4
Corrections published
The latest
All audits →Claim audit · SemaxAnimal
Semax Isn't Under-Researched. It's Under-Translated.
Decades of work exists on this peptide. Almost nothing an English reader can actually open says a word about human cognition, and I sell the stuff.
Claim audit · SemaxAnimal
Semax Is Approved in Russia. That's a Fact About a Regulator, Not a Result.
I went looking for the human trial I could hand you and came back with mice, a negative result, and one honest reason the Western data is thin.
Claim audit · SemaxAnimal
Everyone Opens With "Semax Is Approved in Russia." Approval and Replication Are Two Different Columns.
A three-column test for reading any compound whose evidence sits behind a language border, and what the English-language literature on Semax actually contains.
Claim audit · SemaxAnimal
"It's an Approved Drug in Russia." That's the Weakest Argument for Semax, Not the Strongest.
Semax has a real evidence base, which is exactly what makes it easy to overstate: almost none of it was collected in healthy people at a desk, and almost nobody outside its home research tradition has checked it.
Claim audit · SemaxAnimal
Semax Has Been Used Clinically for Decades. That's a Claim About Russia, Not About Cognition.
The most convincing sentence in the Semax conversation is a fact about a healthcare system, and buyers keep mistaking it for evidence about a molecule.
Claim audit · retatrutide
Lilly Sued Six Sellers Over Retatrutide. The Real Defendant Is Three Words.
The suits are aimed at "research use only", which is the sentence this whole market is built on, including the footer of the shop you buy from.
Claim audit · retatrutide
Lilly Cannot Sue Anyone for Selling an Unapproved Drug. So What Is the Claim?
A reader asked how you sue over a drug nobody is allowed to sell yet. The answer runs through a 2014 Supreme Court case and one word in it: "or".
Claim audit · BPC-157Expert commentary
BPC-157 Wasn't Banned. It Was Left Off a List.
Four separate regulatory facts get crushed into the word 'legal,' and almost every confident answer online is answering a question you didn't ask.
Claim audit · SemaxAnimal
"Approved in Russia Since the 1990s." That's a Fact About Russia, Not About Semax.
I sell Semax, and when I followed the claims about it back to their sources, most of them stopped within two clicks. Here's how to tell which ones stop where.
Claim audit · GHK-CuAnimal
GHK-Cu and KPV Are Both Three Amino Acids Long. That's Where the Resemblance Ends.
They share a shelf heading, not a mechanism. Here is the four-point test I run before I let the word "versus" into a sentence about two compounds.
Claim audit · MOTS-cAnimal
MOTS-c and SS-31 Are Not Two Versions of the Same Idea. One Is a Signal, One Is a Scaffold.
They share an address inside the cell and almost nothing else, which is why reading one's evidence into the other will steer you wrong.
Clip
2:44Why this exists
Clip
1:26Epitalon's entire claim to fame is one enzyme
Claim audit · CJC-1295Expert commentary
Tesamorelin Is Approved. CJC-1295 Is Living Off Its Reputation.
The GH-axis peptides are not one evidence base, they're a steep ladder, and the rung most buyers think they're standing on isn't the one they're on.